After being hailed as a triumph of public-private drug development, Moderna's partnership with the US government on its COVID-19 vaccine ... Moderna's mRNA-1273 shot. The patent has been filed ...

Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending.

A healthcare provider gives a patient a Covid shot. The FDA approved new COVID-19 vaccines from Pfizer and Moderna on Thursday ... COVID-19 cases historically spike during the fall and winter ...

New COVID-19 shots are now ... to four months after receiving the shot, Marks says. The FDA gave the OK for anyone ages 6 months and older to get the Moderna or Pfizer-BioNtech vaccines.

Moderna said the Spikevax 2024-2025 formula is expected to be available across the U.S. in the days immediately following approval. Pfizer also said shipping will begin immediately. Thursday, the ...

US regulators approved updated versions of the Covid-19 vaccines made by Pfizer Inc. and Moderna Inc. as infections climb across the country. The vaccines, which will target the currently ...

The background: On Thursday, the Food and Drug Administration (FDA) signed off on these updated COVID vaccines from Moderna ... cases start to rise earlier, you should seek out your flu shot ...

Also Read: Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of ... evolution of SARS-CoV-2 and a rise in cases of COVID-19, the agency subsequently determined ...

Two of the updated COVID-19 vaccines have arrived at pharmacies all over the country. On Friday, the FDA authorized the Novavax shot ... the Pfizer-BioNTech and Moderna shots, and now a third ...

The approval comes for the updated vaccines from Moderna ... COVID-19 vaccines (2024-2025 formula) should be monovalent JN.1 vaccines. Based on the further evolution of SARS-CoV-2 and a rise in ...